Hyderabad, (Telangana) [India] 22 October 2026: Mrs. Lanre Tunji-Ajayi, M.S.M., Chief Executive Officer of the Global Action Network for Sickle Cell and Other Inherited Blood Disorders (GANSID), Mr. Chandrakant Agrawal, President – Thalassemia and Sickle Cell Society, Hyderabad addressed the press at the Thalassemia and Sickle Cell Society (TSCS), Shivarampally, Hyderabad, on the upcoming 4th GANSID Congress 2026, scheduled to be held from 23rd to 25th October 2026 at the Hyderabad International Convention Centre (HICC)–Novotel, Madhapur, Hyderabad. Present during the inauguration announcement were Dr. Suman Jain – Chief Medical Research Officer and Secretary – TSCS, Mrs. Ratnavali – Sr. Vice President -TSCS, Aleem Baig, Joint Secretary – TSCS, Manoj Rupani, Treasurer along with Naresh Rathi.
The 4th GANSID Congress 2026 is an international conference dedicated to sickle cell anaemia, thalassemia and other inherited blood disorders. The congress aims to bring together medical experts, researchers, healthcare professionals, policymakers, patient organisations, advocacy groups and other stakeholders to share knowledge, discuss developments in diagnosis and treatment, and strengthen collaboration in the prevention and management of inherited blood disorders.
The Thalassemia and Sickle Cell Society (TSCS), Hyderabad, is the local partner for GANSID Congress 2026. TSCS is a non-profit organisation supporting over 4,800 patients affected by thalassemia, sickle cell disease and other inherited blood disorders. Its work includes blood transfusion support, awareness and prevention programmes, antenatal screening, patient counselling and assistance for bone marrow transplantation.
Through its partnership with GANSID, TSCS aims to strengthen international cooperation, increase awareness and promote better healthcare and support systems for patients and their families.
The congress will provide a platform for exchanging scientific knowledge, sharing best practices, raising public awareness and promoting improved access to comprehensive care for patients and families affected by these lifelong conditions. It will also encourage stronger partnerships among healthcare institutions, governments, civil society organisations and international networks to improve patient outcomes.
The congress is expected to bring together 700 registered delegates, including speakers and participants from 27 countries. Participants will include national and international medical specialists, researchers, healthcare professionals, representatives of patient organisations, policymakers and community advocates working in the field of inherited blood disorders.
Their participation will provide opportunities to exchange experiences, discuss advances in patient care and research, and develop collaborative approaches to addressing the challenges faced by individuals living with sickle cell disease, thalassemia and other inherited blood disorders.
GANSID Congress 2026 represents an important opportunity for the medical community, patient organisations and international partners to work together towards improved prevention, diagnosis, treatment and long-term care for inherited blood disorders.
The three-day congress in Hyderabad is expected to encourage meaningful discussions, strengthen professional networks and reinforce the shared commitment to improving the quality of life of affected individuals and their families.
Event Details
- Event: 4th GANSID Congress 2026 – International Conference on Sickle Cell Anaemia and Inherited Blood Disorders
- Dates: 23–25 October 2026
- Venue: Hyderabad International Convention Centre (HICC)–Novotel, Madhapur, Hyderabad, Telangana
- Press Release Date: 22 October 2026
- Issued by: Global Action Network for Sickle Cell and Other Inherited Blood Disorders (GANSID), in collaboration with Thalassemia and Sickle Cell Society (TSCS), Hyderabad
